What's in Beijing Dongfang Biotech Co., Ltd.'s pipeline?

Beijing Dongfang Biotech Co., Ltd. has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Beijing Dongfang Biotech Co., Ltd.'s portfolio?

Top competitors by shared drug class: Amsterdam UMC, location VUmc, Assistance Publique Hopitaux De Marseille, Astellas Pharma Inc, AstraZeneca, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/beijing-dongfang-biotech-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Beijing Dongfang Biotech Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beijing Dongfang Biotech Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Exendin-4 Fc fusion protein injection	Exendin-4 Fc fusion protein injection	phase 3	GLP-1 receptor agonist	GLP-1R	Diabetes

Therapeutic area mix

Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amsterdam UMC, location VUmc · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
AstraZeneca · 1 shared drug class
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders · 1 shared drug class
Beijing Chao Yang Hospital · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class
AbbVie · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Beijing Dongfang Biotech Co., Ltd.:

Cite this brief

Drug Landscape (2026). Beijing Dongfang Biotech Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beijing-dongfang-biotech-co-ltd. Accessed 2026-05-16.